Cargando…
Mutant p53 gain of function induces HER2 over-expression in cancer cells
BACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors. Clinical associations have reported that somatic mutations of p53 more frequently detected in cases of sporadic breast cancer of the HER2 subtypes, besides a high percentage of HER2-ampl...
Autores principales: | Román-Rosales, A. A., García-Villa, E., Herrera, L. A., Gariglio, P., Díaz-Chávez, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029411/ https://www.ncbi.nlm.nih.gov/pubmed/29970031 http://dx.doi.org/10.1186/s12885-018-4613-1 |
Ejemplares similares
-
Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer
por: Madrigal, Tzitzijanik, et al.
Publicado: (2021) -
Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007) -
Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells
por: Madrigal, Tzitzijanik, et al.
Publicado: (2023) -
Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019) -
Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)